Share This Link

Digoxin (Lanoxin) is a cardiac glycoside used to increase the force of heart contractions and slow the heart rate. While it may be used to manage the symptoms of heart failure caused by a large PDA, it has no physiological mechanism to actually close the ductus arteriosus.

Prednisone is a corticosteroid used to reduce inflammation. It is not used in the treatment of PDA. While steroids are sometimes given to mothers before preterm birth to help mature the infant's lungs, they do not play a role in the postnatal closure of the ductus.

Furosemide (Lasix) is a loop diuretic used to remove excess fluid from the lungs and body. Like Digoxin, it manages the symptoms of pulmonary congestion (the "wet lungs") associated with PDA, but it does not address the underlying structural defect.

Pulmonary hypertension in newborns involves high resistance in the pulmonary vascular bed, often leading to right-to-left shunting through fetal pathways. While it causes hypoxemia, it typically presents with a loud second heart sound (S2) and a systolic murmur of tricuspid regurgitation. It does not produce the classic continuous machinery-like sound or the wide pulse pressure associated with a persistent ductal connection.

A ventricular septal defect (VSD) is characterized by a harsh holosystolic murmur best heard at the left lower sternal border. While a large VSD can cause heart failure and respiratory distress, it does not create a continuous murmur because the pressure gradient exists primarily during systole. Furthermore, VSDs are not typically associated with the bounding pulses or wide pulse pressures seen in ductal shunting.

Bronchopulmonary dysplasia is a chronic lung disease resulting from long-term mechanical ventilation and oxygen therapy in premature infants. It manifests as tachypnea, crackles, and wheezing due to alveolar damage and fibrosis rather than a structural heart defect. While these infants may have heart strain (cor pulmonale), they do not present with the specific vascular murmur described in the assessment.

Atrial stenosis is not a standard term for a common congenital heart defect. Stenosis refers to the narrowing of a valve or vessel, such as aortic or pulmonic stenosis. It does not describe an open communication between the aorta and pulmonary artery.

Atrial septal defect (ASD) refers to an opening in the septum (wall) between the two upper chambers of the heart, the atria. While it is a left-to-right shunt, it occurs within the heart itself, not between the great arteries (aorta and pulmonary artery).

Ventricular septal defect (VSD) refers to an opening in the septum between the two lower chambers of the heart, the ventricles. This is the most common congenital heart defect, but like the ASD, it is an internal heart defect rather than a persistent fetal vessel.

Blood flowing from the pulmonary artery to the aorta describes a right-to-left shunt, which occurs primarily in fetal life or in certain cyanotic defects. In a typical PDA after the first few days of life, this direction is reversed because the systemic pressure is higher. If blood moved in this direction postnatally, it would result in systemic hypoxemia and cyanosis of the lower extremities.

In the transition to extrauterine life, systemic vascular resistance actually increases due to the removal of the low-resistance placental circuit. A decrease in systemic resistance would reduce the pressure gradient that drives the left-to-right shunt through the ductus. The pathophysiology of PDA is driven by the fact that systemic resistance is relatively high, forcing blood through any available escape path.

If pulmonary resistance exceeded systemic resistance, blood would shunt away from the lungs toward the aorta, a condition known as Eisenmenger syndrome. This reversal of the shunt occurs only after prolonged, untreated pulmonary overcirculation leads to vascular remodeling. In the initial presentation of PDA, pulmonary resistance is lower than systemic resistance, which is why pulmonary blood flow increases

Digoxin (Lanoxin) is a cardiac glycoside used to increase the force of heart contractions and slow the heart rate. While it may be used to manage the symptoms of heart failure caused by a large PDA, it has no physiological mechanism to actually close the ductus arteriosus.

Prednisone is a corticosteroid used to reduce inflammation. It is not used in the treatment of PDA. While steroids are sometimes given to mothers before preterm birth to help mature the infant's lungs, they do not play a role in the postnatal closure of the ductus.

Furosemide (Lasix) is a loop diuretic used to remove excess fluid from the lungs and body. Like Digoxin, it manages the symptoms of pulmonary congestion (the "wet lungs") associated with PDA, but it does not address the underlying structural defect.